Reaction
Blood Electrolytes Decreased reporting signals
As of the last recalculation, Blood Electrolytes Decreased appears in 1,400 FAERS reports alongside 23 co-occurring drug terms. The strongest observed disproportionality signal is TEDUGLUTIDE (PRR 17.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Teduglutide | 16 | 17.8 | 17.9 |
| Standardized Senna Concentrate | 11 | 13.1 | 13.1 |
| Lanreotide Acetate | 4 | 7.6 | 7.6 |
| Riociguat | 16 | 7.4 | 7.4 |
| Dofetilide | 5 | 7.1 | 7.1 |
| Irinotecan Hydrochloride | 6 | 7.0 | 7.0 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 4 | 6.9 | 6.9 |
| Nintedanib | 14 | 6.7 | 6.7 |
| Regorafenib | 5 | 6.4 | 6.4 |
| Avapritinib | 5 | 6.2 | 6.2 |
| Niraparib | 9 | 6.1 | 6.1 |
| Abemaciclib | 8 | 6.0 | 6.0 |
| Lenvatinib | 13 | 5.9 | 5.9 |
| Vismodegib | 3 | 5.0 | 5.0 |
| Cetuximab | 10 | 4.8 | 4.8 |
| Treprostinil | 37 | 4.5 | 4.5 |
| Cabozantinib | 14 | 4.4 | 4.4 |
| Trifluridine And Tipiracil | 3 | 4.2 | 4.2 |
| Lenalidomide | 109 | 4.1 | 4.1 |
| Palivizumab | 4 | 3.9 | 3.9 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 6 | 2.9 | 2.9 |
| Pomalidomide | 19 | 2.8 | 2.8 |
| Tirzepatide | 19 | 1.8 | 1.8 |